SG11201400964PA - Formulations based on solid dispersions - Google Patents
Formulations based on solid dispersionsInfo
- Publication number
- SG11201400964PA SG11201400964PA SG11201400964PA SG11201400964PA SG11201400964PA SG 11201400964P A SG11201400964P A SG 11201400964PA SG 11201400964P A SG11201400964P A SG 11201400964PA SG 11201400964P A SG11201400964P A SG 11201400964PA SG 11201400964P A SG11201400964P A SG 11201400964PA
- Authority
- SG
- Singapore
- Prior art keywords
- solid dispersions
- formulations based
- formulations
- dispersions
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11182792A EP2572731A1 (de) | 2011-09-26 | 2011-09-26 | Formulierungen basierend auf Festdispergierungen |
| PCT/EP2012/068661 WO2013045365A1 (en) | 2011-09-26 | 2012-09-21 | Formulations based on solid dispersions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201400964PA true SG11201400964PA (en) | 2014-04-28 |
Family
ID=46875866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201400964PA SG11201400964PA (en) | 2011-09-26 | 2012-09-21 | Formulations based on solid dispersions |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20140296341A1 (de) |
| EP (2) | EP2572731A1 (de) |
| JP (2) | JP2014527976A (de) |
| KR (1) | KR20140069215A (de) |
| CN (1) | CN104039354B (de) |
| AU (1) | AU2012314661B2 (de) |
| BR (1) | BR112014006608A2 (de) |
| CA (1) | CA2847800A1 (de) |
| CO (1) | CO7071123A2 (de) |
| HK (1) | HK1200700A1 (de) |
| IL (1) | IL231384A0 (de) |
| MX (1) | MX2014003673A (de) |
| RU (1) | RU2014116987A (de) |
| SG (1) | SG11201400964PA (de) |
| WO (1) | WO2013045365A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012351948A1 (en) * | 2011-12-16 | 2014-07-10 | Allergan, Inc. | Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer |
| DK3091981T3 (da) * | 2014-01-09 | 2021-05-31 | Verastem Inc | Sammensætninger og fremgangsmåder til behandling af abnorm cellevækst |
| CN104857515B (zh) * | 2014-02-25 | 2020-01-10 | 中国科学院上海药物研究所 | 一种控释给药的药芯组合物以及包含该药芯组合物的渗透泵制剂 |
| CN105769753B (zh) * | 2016-04-19 | 2019-10-29 | 浙江工业大学 | 一种温敏凝胶基质及其制备方法与应用 |
| CN106937943A (zh) * | 2017-04-20 | 2017-07-11 | 上药东英（江苏）药业有限公司 | 一种培哚普利及其盐的soluplus复合物固体分散体及其制备 |
| SI3644970T1 (sl) * | 2017-06-30 | 2022-05-31 | Acrotech Biopharma Llc | Nove oralne formulacije belinostata |
| JPWO2020027011A1 (ja) * | 2018-07-30 | 2021-08-02 | 中外製薬株式会社 | ヒダントイン誘導体の固体分散体 |
| EP3886993A1 (de) * | 2018-11-27 | 2021-10-06 | Colgate-Palmolive Company | Mundpflegegerät mit einer lösekomponente |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5071643A (en) * | 1986-10-17 | 1991-12-10 | R. P. Scherer Corporation | Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
| EP1027886B1 (de) * | 1999-02-10 | 2008-07-09 | Pfizer Products Inc. | Pharmazeutische feste Dispersionen |
| US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| DE102005053066A1 (de) * | 2005-11-04 | 2007-05-10 | Basf Ag | Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen |
| WO2008037809A1 (en) * | 2006-09-29 | 2008-04-03 | Abbott Gmbh & Co. Kg | Transmucosal administration of fibrate compounds and delivery system therefor |
| CN101765616A (zh) | 2007-07-26 | 2010-06-30 | 巴斯夫欧洲公司 | 制备通过接枝聚合在溶液中获得的并基于固体聚醚的共聚物的方法 |
| EP2344138B1 (de) * | 2008-09-25 | 2014-07-16 | Basf Se | Verwendung von copolymeren auf basis von polyethern und vinylmonomeren als bindemittel für feste wirkstoffhaltige dosierungsformen |
| US8790703B2 (en) * | 2009-03-31 | 2014-07-29 | Basf Se | Method for producing preparations of substances poorly soluble in water |
| WO2010130728A2 (de) * | 2009-05-13 | 2010-11-18 | Basf Se | Feste pharmazeutischen zubereitungen enthaltend copolymere auf basis von polyethern in kombination mit wasserschwerlöslichen polymeren |
| WO2011063164A2 (en) * | 2009-11-18 | 2011-05-26 | Steady Sleep Rx Co., Inc. | Sustained release cannabinoid medicaments |
| WO2011064111A1 (en) * | 2009-11-24 | 2011-06-03 | Basf Se | Film-like pharmaceutical dosage forms |
| EP2536393B1 (de) * | 2010-02-18 | 2014-04-16 | AbbVie Deutschland GmbH & Co KG | Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit graft copolymeren |
-
2011
- 2011-09-26 EP EP11182792A patent/EP2572731A1/de not_active Withdrawn
-
2012
- 2012-09-21 EP EP12759774.8A patent/EP2760474A1/de not_active Withdrawn
- 2012-09-21 KR KR1020147010604A patent/KR20140069215A/ko not_active Application Discontinuation
- 2012-09-21 RU RU2014116987/15A patent/RU2014116987A/ru not_active Application Discontinuation
- 2012-09-21 US US14/346,686 patent/US20140296341A1/en not_active Abandoned
- 2012-09-21 BR BR112014006608A patent/BR112014006608A2/pt not_active Application Discontinuation
- 2012-09-21 CA CA2847800A patent/CA2847800A1/en not_active Abandoned
- 2012-09-21 JP JP2014531246A patent/JP2014527976A/ja active Pending
- 2012-09-21 SG SG11201400964PA patent/SG11201400964PA/en unknown
- 2012-09-21 CN CN201280046875.4A patent/CN104039354B/zh not_active Expired - Fee Related
- 2012-09-21 AU AU2012314661A patent/AU2012314661B2/en not_active Ceased
- 2012-09-21 MX MX2014003673A patent/MX2014003673A/es unknown
- 2012-09-21 WO PCT/EP2012/068661 patent/WO2013045365A1/en active Application Filing
-
2014
- 2014-03-06 IL IL231384A patent/IL231384A0/en unknown
- 2014-04-23 CO CO14086039A patent/CO7071123A2/es unknown
-
2015
- 2015-02-03 HK HK15101149.1A patent/HK1200700A1/xx unknown
-
2017
- 2017-06-21 JP JP2017121100A patent/JP2017200938A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014003673A (es) | 2014-10-13 |
| JP2014527976A (ja) | 2014-10-23 |
| CN104039354A (zh) | 2014-09-10 |
| AU2012314661B2 (en) | 2017-08-03 |
| BR112014006608A2 (pt) | 2017-04-25 |
| AU2012314661A1 (en) | 2014-03-20 |
| CN104039354B (zh) | 2016-09-21 |
| CO7071123A2 (es) | 2014-09-30 |
| CA2847800A1 (en) | 2013-04-04 |
| WO2013045365A1 (en) | 2013-04-04 |
| NZ621872A (en) | 2015-10-30 |
| JP2017200938A (ja) | 2017-11-09 |
| US20140296341A1 (en) | 2014-10-02 |
| RU2014116987A (ru) | 2015-11-10 |
| KR20140069215A (ko) | 2014-06-09 |
| HK1200700A1 (en) | 2015-08-14 |
| EP2760474A1 (de) | 2014-08-06 |
| IL231384A0 (en) | 2014-04-30 |
| EP2572731A1 (de) | 2013-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2765990T (lt) | Solidinė dispersija | |
| GB201111438D0 (en) | Formulation | |
| HK1189834A1 (zh) | 基於固體分散體的固體延緩配方 | |
| AP3879A (en) | An improved herbicidal formulation | |
| ZA201309221B (en) | Formulation | |
| HK1200700A1 (en) | Formulations based on solid dispersions | |
| IL230305A (en) | Milk-based compound | |
| PL2753311T3 (pl) | Preparaty antyoksydacyjne | |
| ZA201402456B (en) | Formulation | |
| HRP20151339T8 (en) | Composition based on ubidecarenone | |
| GB201110278D0 (en) | Formulations | |
| GB201106958D0 (en) | Formulation | |
| GB201111578D0 (en) | Pharmeutical formulations | |
| GB201111013D0 (en) | Formulations | |
| GB201107626D0 (en) | Formulations | |
| GB201107627D0 (en) | Formulations | |
| GB201105410D0 (en) | Formulations | |
| GB201105360D0 (en) | Formulations | |
| GB201104049D0 (en) | Formulations | |
| GB201104048D0 (en) | Formulations | |
| GB201102795D0 (en) | Formulations | |
| GB201109554D0 (en) | Quick hitch | |
| GB201104284D0 (en) | Formulation | |
| AU2012905689A0 (en) | Imaging agents | |
| AU2011905352A0 (en) | Imaging agents |